{"Symbol": "RMD", "AssetType": "Common Stock", "Name": "ResMed Inc", "Description": "ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.", "CIK": "943819", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS", "Address": "9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, US", "OfficialSite": "https://www.resmed.com", "FiscalYearEnd": "June", "LatestQuarter": "2024-12-31", "MarketCapitalization": "31441289000", "EBITDA": "1712289000", "PERatio": "25.25", "PEGRatio": "1.392", "BookValue": "35.77", "DividendPerShare": "2.02", "DividendYield": "0.0099", "EPS": "8.48", "RevenuePerShareTTM": "33.54", "ProfitMargin": "0.254", "OperatingMarginTTM": "0.325", "ReturnOnAssetsTTM": "0.139", "ReturnOnEquityTTM": "0.257", "RevenueTTM": "4926773000", "GrossProfitTTM": "2907906000", "DilutedEPSTTM": "8.48", "QuarterlyEarningsGrowthYOY": "0.649", "QuarterlyRevenueGrowthYOY": "0.103", "AnalystTargetPrice": "265.42", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "8", "AnalystRatingHold": "6", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "0", "TrailingPE": "25.25", "ForwardPE": "20.92", "PriceToSalesRatioTTM": "6.38", "PriceToBookRatio": "5.99", "EVToRevenue": "6.45", "EVToEBITDA": "18.62", "Beta": "0.755", "52WeekHigh": "262.46", "52WeekLow": "177.39", "50DayMovingAverage": "223.86", "200DayMovingAverage": "231.76", "SharesOutstanding": "146867000", "DividendDate": "2025-03-20", "ExDividendDate": "2025-02-13"}